Susquehanna International Group, LLP Eton Pharmaceuticals, Inc. Call Options Transaction History

Susquehanna International Group, LLP

15 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2025 Aug 14, 2025	BUY	$11.47 - $20.24 $2.28 Million - $4.02 Million	198,500 New	198,500 $2.83 Million
Q4 2024 Feb 14, 2025	BUY	$5.9 - $13.15 $440,730 - $982,305	74,700 Added 498.0%	89,700 $1.18 Million
Q3 2024 Nov 14, 2024	SELL	$3.28 - $6.0 $38,376 - $70,200	-11,700 Reduced 43.82%	15,000 $90,000
Q2 2024 Aug 15, 2024	BUY	$3.06 - $3.75 $7,650 - $9,375	2,500 Added 10.33%	26,700 $87,000
Q1 2024 May 07, 2024	BUY	$3.48 - $5.03 $42,108 - $60,863	12,100 Added 100.0%	24,200 $90,000
Q4 2023 Feb 14, 2024	SELL	$3.45 - $4.66 $35,190 - $47,532	-10,200 Reduced 45.74%	12,100 $52,000
Q3 2023 Nov 14, 2023	BUY	$2.55 - $5.63 $56,864 - $125,549	22,300 New	22,300 $92,000
Q4 2022 Feb 14, 2023	SELL	$2.02 - $3.25 $65,044 - $104,650	-32,200 Reduced 53.58%	27,900 $78,000
Q3 2022 Nov 14, 2022	SELL	$2.04 - $3.03 $12,036 - $17,877	-5,900 Reduced 8.94%	60,100 $126,000
Q2 2022 Aug 15, 2022	SELL	$2.55 - $4.38 $23,460 - $40,296	-9,200 Reduced 12.23%	66,000 $173,000
Q1 2022 May 16, 2022	BUY	$3.43 - $4.69 $188,307 - $257,481	54,900 Added 270.44%	75,200 $328,000
Q4 2021 Feb 14, 2022	SELL	$3.66 - $6.59 $118,950 - $214,175	-32,500 Reduced 61.55%	20,300 $87,000
Q3 2021 Nov 15, 2021	SELL	$4.2 - $6.26 $107,940 - $160,882	-25,700 Reduced 32.74%	52,800 $266,000
Q2 2021 Aug 11, 2021	BUY	$5.71 - $8.85 $391,135 - $606,225	68,500 Added 685.0%	78,500 $484,000
Q1 2021 May 17, 2021	BUY	$6.93 - $10.07 $69,300 - $100,700	10,000 New	10,000 $73,000

15M

242K

11.8K

Ticker ETON
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,297,000
Market Cap $497M
Description
Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for th...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.